Patient-reported outcomes in NAFLD/NASH clinical trials: A blind spot that needs addressing

JHEP Rep. 2022 Sep 22;5(1):100597. doi: 10.1016/j.jhepr.2022.100597. eCollection 2023 Jan.

Elena Sena¹, Ramiro Manzano-Nunez¹, Jesus Rivera-Esteban^{1

2

3}, Juan M Pericas^{1

2

3

4}

¹ Liver Unit, Vall d'Hebron Institute for Research, Barcelona, Spain.
² Liver Unit, Vall d'Hebron University Hospital, Barcelona, Spain.
³ Universitat Autònoma de Barcelona, Bellaterra, Spain.
⁴ Centros de Investigación Biomédica en Red, Enfermedades Hepáticas y Digestivas (CIBERehd), Madrid, Spain.

No abstract available

Keywords: Health-related quality of life; Non-alcoholic fatty liver disease; Non-alcoholic steatohepatitis; Patient-reported outcomes.